Evidence map›Paper›PMID 34197781›Full record

ArticleAmerican journal of ophthalmology2022

The Impact of COVID-19 and Pandemic Mitigation Measures on Persons With Sensory Impairment.

Alec Bernard, Sara Weiss, Moshiur Rahman, Sheryl S Ulin, Clive D'Souza, Anah Salgat, Kate Panzer, Joshua D Stein, Michelle A Meade, Michael M McKee and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Can Digital Communication Protect Against Depression for Older Adults With Hearing and Vision Impairment During COVID-19?The journals of gerontology. Series B, Psychological sciences and social sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alec BernardUniversity of Michigan Medical School, Ann Arbor, Michigan, USA.
Sara WeissDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Moshiur RahmanDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Sheryl S UlinCenter for Ergonomics, Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan, USA.
Clive D'SouzaCenter for Ergonomics, Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan, USA.
Anah SalgatDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kate PanzerUniversity of Michigan Medical School, Ann Arbor, Michigan, USA.
Joshua D SteinDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA; Department Health Policy and Management, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
Michelle A MeadeDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA; Center for Disability Health and Wellness, University of Michigan, Ann Arbor, Michigan, USA; Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA.
Michael M McKeeDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA; Center for Disability Health and Wellness, University of Michigan, Ann Arbor, Michigan, USA.
Joshua R EhrlichDepartment of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan, USA; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan, USA; Center for Disability Health and Wellness, University of Michigan, Ann Arbor, Michigan, USA; Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, Michigan, USA; Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: joshre@med.umich.edu.
University of Michigan · US

Funding

NRSA Training CoreTL1TR002242 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLINSTAT, MICHAEL ALLAN · 2017 to 2021
$2.8M
Addressing Low Vision due to Severe Peripheral Field Loss: Development and Validation of a Patient-Centered Outcome MeasureK23EY027848 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI EHRLICH, JOSHUA ROBERT · 2017 to 2021
$1.2M
NCATS NIH HHS TL1 TR002242NEI NIH HHS K23 EY027848
6 · The paper itself

Abstract

purposeTo assess the impact of the COVID-19 pandemic and associated mitigation measures on persons with sensory impairments (SI), including visual impairments (VI) and hearing impairments (HI).

designCross-sectional survey.

methodsAdults with VI (best-corrected visual acuity <20/60 in the better-seeing eye), HI (International Classification of Diseases, Tenth Revision, codes), and age- and sex-matched controls (n = 375) were recruited from the University of Michigan. The 34-item Coronavirus Disability Survey was administered. Both χ

resultsAll groups reported high levels of disruption of daily life, with 80% reporting "a fair amount" or "a lot" of disruption (VI: 76%, HI: 83%, CT: 82%, P = .33). Participants with VI had greater difficulty with day-to-day activities and were more likely to cite the following reasons: caregiver was worried about COVID-19 (odds ratio [OR]

conclusionsIndividuals with VI have experienced increased disruption and challenges in daily activities related to the pandemic. People with SI may benefit from targeted policy approaches to the current pandemic and future stressors. Minimal differences in some survey measures may be due to the large impact of the pandemic on the population as a whole. The SARS-CoV-2 (COVID-19) pandemic and public health mitigation measures have had an exceedingly large impact around the globe. As of the time of writing, more than 114 million global cases (28 million US) had been diagnosed, and there had been more than 2.5 million fatalities attributed to COVID-19 (517,000 US).

Indexed as

COVID-19AdultCross-Sectional StudiesHumansPandemicsSARS-CoV-2Surveys and Questionnaires

Identifiers

PMID34197781
PMCPMC8238639
OpenAlexW3174631354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.